D.A. Davidson & Co’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.8M Sell
206,370
-8,257
-4% -$636K 0.09% 182
2025
Q4
$17M Buy
214,627
+6,138
+3% +$484K 0.1% 154
2025
Q3
$15.7M Buy
208,489
+3,728
+2% +$255K 0.1% 159
2025
Q2
$14.1M Buy
204,761
+23,403
+13% +$1.53M 0.1% 162
2025
Q1
$12.3M Sell
181,358
-6,467
-3% -$387K 0.1% 165
2024
Q4
$8.43M Sell
187,825
-15,108
-7% -$848K 0.07% 213
2024
Q3
$12.8M Sell
202,933
-38,478
-16% -$2.24M 0.11% 151
2024
Q2
$14.3M Sell
241,411
-109,388
-31% -$6.84M 0.13% 128
2024
Q1
$28M Sell
350,799
-9,751
-3% -$745K 0.25% 74
2023
Q4
$28.5M Sell
360,550
-16,743
-4% -$1.19M 0.28% 67
2023
Q3
$26.3M Sell
377,293
-26,692
-7% -$1.89M 0.29% 67
2023
Q2
$27.9M Sell
403,985
-8,792
-2% -$626K 0.29% 64
2023
Q1
$30.7M Sell
412,777
-14,279
-3% -$1.2M 0.35% 55
2022
Q4
$39.8M Sell
427,056
-43,759
-9% -$4.22M 0.47% 47
2022
Q3
$44.9M Sell
470,815
-600
-0.1% -$59.4K 0.59% 33
2022
Q2
$43.7M Buy
471,415
+22,264
+5% +$2.17M 0.55% 36
2022
Q1
$45.5M Sell
449,151
-17,301
-4% -$1.82M 0.5% 41
2021
Q4
$48.1M Buy
466,452
+1,143
+0.2% +$106K 0.51% 35
2021
Q3
$39.5M Buy
465,309
+16,897
+4% +$1.42M 0.46% 41
2021
Q2
$37.4M Buy
448,412
+7,546
+2% +$618K 0.44% 46
2021
Q1
$33.2M Buy
440,866
+56,000
+15% +$4.08M 0.42% 50
2020
Q4
$26.3M Sell
384,866
-25,393
-6% -$1.65M 0.4% 53
2020
Q3
$24M Buy
410,259
+31,863
+8% +$1.98M 0.42% 52
2020
Q2
$24.6M Sell
378,396
-59,858
-14% -$3.77M 0.46% 48
2020
Q1
$26M Buy
438,254
+35,885
+9% +$2.4M 0.51% 44
2019
Q4
$29.9M Sell
402,369
-5,767
-1% -$405K 0.48% 47
2019
Q3
$25.7M Buy
408,136
+18,167
+5% +$1.08M 0.46% 48
2019
Q2
$21.2M Buy
389,969
+85,442
+28% +$4.6M 0.4% 54
2019
Q1
$17.1M Sell
304,527
-22,656
-7% -$1.4M 0.29% 64
2018
Q4
$21.4M Sell
327,183
-255,815
-44% -$19.1M 0.42% 50
2018
Q3
$45.9M Buy
582,998
+18,368
+3% +$1.31M 0.82% 23
2018
Q2
$36.3M Buy
564,630
+42,511
+8% +$2.8M 0.71% 27
2018
Q1
$32.5M Buy
522,119
+7,510
+1% +$539K 0.67% 33
2017
Q4
$37.3M Sell
514,609
-151,709
-23% -$11M 0.78% 25
2017
Q3
$54.2M Buy
666,318
+45,983
+7% +$3.64M 1.06% 10
2017
Q2
$49.9M Buy
620,335
+69,865
+13% +$5.52M 1.13% 11
2017
Q1
$43.2M Buy
550,470
+58,905
+12% +$4.7M 1.05% 13
2016
Q4
$38.8M Buy
491,565
+149,682
+44% +$12.1M 0.88% 17
2016
Q3
$30.4M Buy
341,883
+86,751
+34% +$8.19M 0.76% 21
2016
Q2
$24.4M Buy
255,132
+32,907
+15% +$3.28M 0.72% 21
2016
Q1
$23M Buy
222,225
+119,333
+116% +$11.6M 0.72% 21
2015
Q4
$10.1M Buy
102,892
+61,563
+149% +$6.03M 0.33% 64
2015
Q3
$3.98M Buy
41,329
+941
+2% +$98.9K 0.14% 150
2015
Q2
$4.23M Sell
40,388
-3,023
-7% -$309K 0.14% 152
2015
Q1
$4.47M Sell
43,411
-1,567
-3% -$159K 0.15% 148
2014
Q4
$4.33M Sell
44,978
-4,038
-8% -$356K 0.14% 150
2014
Q3
$3.89M Sell
49,016
-1,544
-3% -$122K 0.13% 146
2014
Q2
$3.8M Sell
50,560
-8
-0% -$605 0.13% 152
2014
Q1
$3.78M Buy
50,568
+2,195
+5% +$155K 0.14% 147
2013
Q4
$3.46M Buy
48,373
+18,345
+61% +$1.18M 0.13% 152
2013
Q3
$1.7M Sell
30,028
-2,449
-8% -$146K 0.08% 245
2013
Q2
$1.85M Buy
+32,477
New +$1.88M 0.09% 222

Other funds holding CVS

D.A. Davidson & Co's CVS Position: Q1 2026 in Review

D.A. Davidson & Co reduced its CVS Health (CVS) stake by 3.8% in Q1 2026, selling an estimated $636K and leaving 206,370 shares worth $14.8M. The position accounts for 0.09% of the portfolio, ranked #182.

D.A. Davidson & Co first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $54.2M in Q3 2017. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • D.A. Davidson & Co held 206,370 shares of CVS Health worth $14.8M as of Q1 2026.
  • D.A. Davidson & Co sold 8,257 CVS Health shares in Q1 2026, an estimated $636K.
  • CVS Health made up 0.09% of D.A. Davidson & Co's portfolio in Q1 2026, its #182 holding.
  • D.A. Davidson & Co first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • D.A. Davidson & Co's CVS Health position peaked at $54.2M in Q3 2017.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on D.A. Davidson & Co's 13F filing for Q1 2026, filed 5 May 2026.